Based on the key indicators related to Stereotaxis' liquidity, profitability, solvency, and operating efficiency, Stereotaxis may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Stereotaxis' Net Receivables is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 90.6 K in 2025, whereas Retained Earnings are likely to drop (589.8 M) in 2025. Key indicators impacting Stereotaxis' financial strength include:
The essential information of the day-to-day investment outlook for Stereotaxis includes many different criteria found on its balance sheet. An individual investor should monitor Stereotaxis' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Stereotaxis.
Please note, the imprecision that can be found in Stereotaxis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stereotaxis. Check Stereotaxis' Beneish M Score to see the likelihood of Stereotaxis' management manipulating its earnings.
Stereotaxis Stock Summary
Stereotaxis competes with Accuray Incorporated, AngioDynamics, AtriCure, and EDAP TMS. Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. Stereotaxis operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 130 people.
Comparative valuation techniques use various fundamental indicators to help in determining Stereotaxis's current stock value. Our valuation model uses many indicators to compare Stereotaxis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stereotaxis competition to find correlations between indicators driving Stereotaxis's intrinsic value. More Info.
Stereotaxis is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Stereotaxis' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Stereotaxis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Stereotaxis Systematic Risk
Stereotaxis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Stereotaxis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Stereotaxis correlated with the market. If Beta is less than 0 Stereotaxis generally moves in the opposite direction as compared to the market. If Stereotaxis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Stereotaxis is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Stereotaxis is generally in the same direction as the market. If Beta > 1 Stereotaxis moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Stereotaxis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stereotaxis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Stereotaxis growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Stereotaxis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stereotaxis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stereotaxis based on widely used predictive technical indicators. In general, we focus on analyzing Stereotaxis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stereotaxis's daily price indicators and compare them against related drivers.
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.